Offer a 15-minute proactive health assessment most traditional primary-care practices don't provide — differentiating your practice and increasing the value of every visit.

ANS testing reveals autonomic imbalances associated with hypertension before it reaches clinical thresholds.
Detect autonomic markers of metabolic syndrome — enabling early intervention for at-risk patients.
Identify orthostatic intolerance that increases fall risk, especially in elderly patients.
HRV and autonomic balance provide a whole-patient health indicator that complements traditional vitals.
Primary care is the front line for preventive medicine, yet many cardiovascular and metabolic risks go undetected until they reach clinical thresholds. Autonomic nervous system testing reveals early-stage dysfunction — autonomic imbalance driving hypertension, reduced heart rate variability preceding metabolic syndrome, and orthostatic intolerance increasing fall risk in elderly patients. The American Diabetes Association recommends autonomic screening for diabetic patients, and the American Heart Association recognizes autonomic dysfunction as an independent cardiovascular risk factor. VitalScan ANS+ brings this testing into the primary care setting with a 15-minute, non-invasive protocol that requires no specialized staff and generates automated interpretive reports immediately.
Primary care practices operate on thin margins and short appointment windows, making any in-office diagnostic that adds revenue without adding time especially valuable. Combined autonomic testing under CPT 95924 and vascular screening under 93922 (ABI) are reimbursable by most major insurers when medical necessity is documented — typically for diabetic patients, hypertensive patients, or those with cardiovascular risk factors. By offering a proactive health assessment that most primary care competitors don't provide, practices differentiate themselves in their market, improve patient retention, and capture revenue from testing that would otherwise be referred out to cardiology or neurology.
US MedResources equips primary care practices nationwide with FDA-cleared autonomic and vascular diagnostic technology. From New York to Los Angeles, Chicago to Miami, practices rely on VitalScan ANS+ for early detection of primary care conditions — with CPT-billable testing that fits into a single patient visit.
Request an ROI & Quote95924Combined autonomic testing — cardiovagal, vasomotor, and sudomotor performed together, ideal for comprehensive preventive screening in primary care93922Limited bilateral ABI study of lower extremities — vascular screening for hypertension, diabetes, and cardiovascular risk in primary care patientsEstimated monthly revenue
3 tests/day × ~$190 avg = $11,400/month
Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.
Adjust the tests you'd run per day and your expected reimbursement for each test type. Your estimated revenue, payback period, and return on investment update instantly.
ANS Comprehensive
CPT 95924
Daily
$600
Sudomotor Function
CPT 95923
Daily
$180
Vascular (ABI / Arterial)
CPT 93922–93924
Daily
$150
Venous Doppler
CPT 93971
Daily
$200
Daily gross revenue
$1,130
5 tests / day
Annual gross reimbursement
$293,800
5 days × 52 weeks
Payback period
2 mo
ROI ratio
6.5X
This mix pays back your $45,000 investment in about 2 months.
Illustrative model based on $45,000 promotional equipment investment and the inputs you choose. Actual reimbursement depends on medical necessity, documentation, payer policy, contracted rates, and claim adjudication. Figures are not a guarantee of reimbursement.
Yes. CPT 95924 (combined autonomic testing) and 93922 (ABI screening) are covered by most major insurers when medical necessity is documented. Common qualifying criteria include diabetes, hypertension, cardiovascular risk factors, or symptoms like dizziness and orthostatic intolerance. Coverage criteria and reimbursement rates vary by payer and region.
Autonomic imbalance — specifically sympathetic overactivity and parasympathetic withdrawal — is one of the earliest measurable signs of developing hypertension, often preceding clinical blood pressure elevation by years. Heart rate variability testing (part of CPT 95924) quantifies this imbalance, allowing primary care providers to identify at-risk patients and intervene with lifestyle modification before pharmacologic treatment becomes necessary.
Yes. VitalScan ANS+ is designed for use by standard clinical staff — medical assistants and nurses can operate the system after brief training. The automated protocols guide the technician through each test, and the system generates interpretive reports immediately, so the reviewing physician does not need to be present during testing.
Get a personalized growth plan with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.